What are the recommended oral antibiotics for treating impetigo?

Oral Antibiotics for Impetigo

For extensive impetigo requiring oral therapy, prescribe cephalexin 250–500 mg four times daily (or 25–50 mg/kg/day divided into 4 doses for children) for exactly 7 days, not 5 days. 1

Treatment Algorithm Based on Disease Extent

Limited Disease (Few Localized Lesions)

• Topical mupirocin 2% ointment twice daily for 5 days is superior to oral antibiotics and should be first-line therapy for limited impetigo. 1, 2
• Topical retapamulin 1% ointment twice daily for 5 days is an alternative for patients ≥9 months old, covering lesions up to 100 cm² in adults or ≤2% body surface area in children. 1

Extensive Disease (Numerous or Widespread Lesions)

• Oral antibiotics are required for extensive impetigo and must be continued for 7 days to ensure clinical cure and limit resistance. 1

First-Line Oral Antibiotic Options

For Presumed Methicillin-Susceptible S. aureus (MSSA)

• Cephalexin 250–500 mg four times daily for adults, or 25–50 mg/kg/day divided into 4 doses for children, for 7 days. 1, 2
• Dicloxacillin 250 mg four times daily for adults, or 25–50 mg/kg/day divided into 4 doses for children, for 7 days. 1, 2
• Amoxicillin-clavulanate is an acceptable alternative when dicloxacillin or cephalexin are not suitable. 2

When MRSA Is Suspected or Confirmed

• Clindamycin 300–450 mg three to four times daily for adults, or 20–30 mg/kg/day divided into 3 doses for children, for 7 days (use only if local MRSA clindamycin resistance <10%). 1, 2
• Trimethoprim-sulfamethoxazole 1–2 double-strength tablets twice daily for adults, or 8–12 mg/kg/day (trimethoprim component) divided into 2 doses for children, for 7 days. 1, 2
• Doxycycline 100 mg twice daily for adults, or 2–4 mg/kg/day divided into 2 doses for children >8 years, for 7 days. 1, 2

Critical Decision Points for MRSA Coverage

Add MRSA-active therapy when any of the following are present:

• Purulent drainage from lesions. 2
• Prior treatment failure with standard antibiotics. 2
• Community CA-MRSA prevalence >10%. 2
• In areas with high MRSA prevalence, empiric MRSA coverage should be initiated until culture results are available. 2

Antibiotics to Avoid

• Penicillin alone is seldom effective for impetigo and should only be used when cultures confirm streptococci alone. 2, 3
• Amoxicillin alone lacks adequate coverage against S. aureus, which is now the predominant causative organism, and should not be used. 2
• Macrolides (erythromycin, azithromycin) show rising resistance rates and should be used only with caution. 2, 4

Treatment Duration: A Common Pitfall

The standard duration for oral antibiotic therapy is 7 days, not the shorter 5-day course used for topical agents. 1, 2 Prescribing oral antibiotics for only 5 days is associated with treatment failure and increased risk of resistance. 1

Special Populations

Penicillin Allergy

• Cephalexin (first-generation cephalosporin) may be used except in patients with immediate hypersensitivity reactions (anaphylaxis, angioedema, urticaria). 2
• Clindamycin 300–450 mg three to four times daily for adults, or 20–30 mg/kg/day in 3 divided doses for children, is the preferred alternative. 2

Children Under 8 Years

• Tetracyclines (doxycycline) must be avoided in children <8 years due to risk of permanent dental staining and impaired bone growth. 1, 2

Pregnant and Breastfeeding Patients

• Cephalexin is considered safe during pregnancy and breastfeeding. 2

Infection Control Measures

Concurrent hygiene interventions are essential alongside antibiotic therapy:

• Keep draining lesions covered with clean, dry bandages. 2
• Maintain good personal hygiene with regular handwashing. 2
• Avoid sharing personal items that contact skin (razors, towels, linens). 2
• Clean high-touch surfaces that may contact bare skin. 2

When to Use Systemic vs. Topical Therapy

Oral antibiotics should be prescribed when:

• Patients have numerous or widespread lesions. 2
• Topical therapy has failed or is impractical. 2
• During outbreak settings to decrease transmission. 1, 2
• Systemic antimicrobials should be used during outbreaks of poststreptococcal glomerulonephritis to eliminate nephritogenic strains. 2

Return-to-Activity Criteria

• Athletes may resume competition after completing at least 72 hours of appropriate antibiotic therapy, provided there have been no new lesions for 48 hours and no moist, exudative, or draining lesions are present. 1
• These return-to-play requirements do not alter the overall treatment duration, which remains 7 days for oral therapy. 1